Form 4 for VCEL Vericel Corp
Accepted 2025-02-07 00:00:00 ET · period of report 2025-02-05 · accession 0001140361-25-003571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-02-07 | 2025-02-05 | VCEL | ZERBE ROBERT L MD | Dir | S - Sale+OE | $62.50 | -2,500 | 26.6K | -9% | -$156.2K |
| DT | 2025-02-07 | 2025-02-05 | VCEL | ZERBE ROBERT L MD | Dir | M - OptEx | $13.05 | +2,500 | 29.1K | +9% | +$32.6K |
| DT | 2025-02-07 | 2025-02-05 | VCEL | ZERBE ROBERT L MD | Dir | M - OptEx | $0.00 | +2,500 | 7,500 | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-05 | S | D | 2,500 | $62.50 | 26,595 | D | — | — | (F1) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024. |
| 2 | Common | Common Stock | 2025-02-05 | M | A | 2,500 | $13.05 | 29,095 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-02-05 | M | A | 2,500 | $0.00 | 7,500 | D | $13.05 · — to 2028-05-02 | 2,500 Common Stock | (F2) These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019. |